Karen I. Maijer

587 total citations
13 papers, 396 citations indexed

About

Karen I. Maijer is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Karen I. Maijer has authored 13 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Karen I. Maijer's work include Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karen I. Maijer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Karen I. Maijer collaborates with scholars based in Netherlands, United Kingdom and Belgium. Karen I. Maijer's co-authors include Daniëlle M. Gerlag, Paul P. Tak, Sander W. Tas, Niek de Vries, M. Safy, Astrid van Tubergen, Man Tang, Mirian Starmans‐Kool, Aeilko H. Zwinderman and M. Janssen and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Annals of the Rheumatic Diseases.

In The Last Decade

Karen I. Maijer

13 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen I. Maijer Netherlands	11	251	107	65	64	50	13	396
M. Safy Netherlands	7	240 1.0×	149 1.4×	64 1.0×	62 1.0×	28 0.6×	10	375
B. Kroegler Italy	10	216 0.9×	179 1.7×	82 1.3×	36 0.6×	39 0.8×	24	383
Karen Hambardzumyan Sweden	9	225 0.9×	63 0.6×	58 0.9×	34 0.5×	29 0.6×	15	282
Lucyna Korman Poland	12	213 0.8×	163 1.5×	65 1.0×	29 0.5×	48 1.0×	27	404
Kim Murphy Australia	8	149 0.6×	195 1.8×	73 1.1×	86 1.3×	45 0.9×	12	411
Serghei Popa Moldova	7	174 0.7×	237 2.2×	61 0.9×	51 0.8×	41 0.8×	15	399
Linda Mathsson‐Alm Sweden	14	369 1.5×	145 1.4×	39 0.6×	208 3.3×	53 1.1×	28	493
Rosanne A. van Schaarenburg Netherlands	9	130 0.5×	265 2.5×	55 0.8×	35 0.5×	39 0.8×	9	334
Emma MacDermott Ireland	7	166 0.7×	164 1.5×	27 0.4×	24 0.4×	64 1.3×	18	334
Iwona Brzosko Poland	8	146 0.6×	125 1.2×	30 0.5×	25 0.4×	39 0.8×	28	276

Countries citing papers authored by Karen I. Maijer

Since Specialization

Citations

This map shows the geographic impact of Karen I. Maijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen I. Maijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen I. Maijer more than expected).

Fields of papers citing papers by Karen I. Maijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen I. Maijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen I. Maijer. The network helps show where Karen I. Maijer may publish in the future.

Co-authorship network of co-authors of Karen I. Maijer

This figure shows the co-authorship network connecting the top 25 collaborators of Karen I. Maijer. A scholar is included among the top collaborators of Karen I. Maijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen I. Maijer. Karen I. Maijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cramer, Steven C., Robert Landewé, Karen I. Maijer, et al.. (2024). The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study. RMD Open. 10(4). e004622–e004622. 1 indexed citations

Brungs, Corinna, Robin Schmid, Ansgar Korf, et al.. (2022). Tattoo Pigment Identification in Inks and Skin Biopsies of Adverse Reactions by Complementary Elemental and Molecular Bioimaging with Mass Spectral Library Matching. Analytical Chemistry. 94(8). 3581–3589. 10 indexed citations

Bent, Sebastiaan A. S. van der, et al.. (2020). Cutaneous non-allergic complications in tattoos: An overview of the literature. La Presse Médicale. 49(4). 104049–104049. 16 indexed citations

Gerlag, Daniëlle M., M. Safy, Karen I. Maijer, et al.. (2018). Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Annals of the Rheumatic Diseases. 78(2). 179–185. 181 indexed citations

Ramwadhdoebé, Tamara H., Johanna F. Semmelink, Karen I. Maijer, et al.. (2018). Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis. Arthritis Research & Therapy. 20(1). 35–35. 25 indexed citations

Choi, Ivy Y., Jason D. Turner, Debbie L. Hardie, et al.. (2017). Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis. PLoS ONE. 12(8). e0182751–e0182751. 31 indexed citations

Maijer, Karen I., N.S. Gudmann, M.A. Karsdal, et al.. (2016). Neo-Epitopes—Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis. PLoS ONE. 11(3). e0149329–e0149329. 21 indexed citations

Ramwadhdoebé, Tamara H., et al.. (2016). Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at‐risk phase of autoantibody positive rheumatoid arthritis. European Journal of Immunology. 46(12). 2812–2821. 26 indexed citations

Maijer, Karen I., Elena Neumann, Ulf Müller‐Ladner, et al.. (2015). Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals. PLoS ONE. 10(12). e0144932–e0144932. 26 indexed citations

10.

Maijer, Karen I., Daniëlle M. Gerlag, & Paul P. Tak. (2015). Prevalence of Anti–Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First‐Degree Relatives of Dutch Rheumatoid Arthritis Patients. Arthritis & Rheumatology. 67(12). 3324–3326. 4 indexed citations

11.

Hair, Maria J. H. de, Karen I. Maijer, M. G. H. Van de Sande, et al.. (2015). Expression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients. PLoS ONE. 10(7). e0133669–e0133669. 12 indexed citations

12.

Maijer, Karen I., Maria J. H. de Hair, Christiaan van der Leij, et al.. (2015). Nuclear Factor-κB–inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort Study. The Journal of Rheumatology. 42(9). 1573–1581. 24 indexed citations

13.

Maijer, Karen I., Christiaan van der Leij, Maria J. H. de Hair, et al.. (2015). Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis. Arthritis & Rheumatology. 68(3). 587–596. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact